Atropine is a type of eye drop called an anti-muscarinic. It dilates the pupil (Mydriasis) and it temporarily paralyses the muscles that help your eyes focus (Cycloplegic). Studies show that Atropine strengthens the scleral (wall of the eye ball), thus reducing eye elongation (which results in myopia). Recent studies by Singapore Eye Research Institute (SERI) found that with a lower concentration of atropine, myopia control is as good, but with fewer to no side effects. Studies have shown that myopia progression in eyes treated with Atropine 0.01% was reduced by 50%.
This treatment is currently not available at Sparks & Feros Optometrists – we are currently reviewing suitability of this treatment with the and may be introducing this treatment mid 2018. If you would like to discuss myopia control phone us on 9872 1555 to arrange an appointment or Click Here to Book Online.
Atropine or Ortho-k?
We currently recommend Ortho-K or sleep lenses for the treatment of myopia progression.
Atropine treatment is currently not available at Sparks & Feros Optometrists however, we are reviewing the suitability of this treatment, if approved we may be introducing this treatment mid 2018.